A primary hepatic lymphoma in a patient with Crohn's disease receiving thiopurine and anti-TNF therapy: a case report
Primary hepatic lymphoma is a rare variant of non-Hodgkin's lymphoma with an incidence of 0.016% of all non-Hodgkin lymphomas. The most common histologic subtype is large diffuse B-cell lymphoma. Pathogenesis is not clearly established and undergoing immunosuppressive therapy has been proposed...
Main Authors: | Salma Merhaben, Shema Ayadi, Monia Tangour, Nadia Boujelbene, Rayfa Ghariani, Leila Mouelhi, Fathi Merhaben |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2023-12-01
|
Series: | Future Science OA |
Subjects: | |
Online Access: | https://www.future-science.com/doi/10.2144/fsoa-2023-0082 |
Similar Items
-
Taking Crohn’s Disease Personally
by: Yehuda Chowers
Published: (2013-04-01) -
Efficacy of Thiopurines in Biologic-Naive Japanese Patients With Crohn's Disease: A Single-Center Experience
by: Takuya Yoshino, et al.
Published: (2015-07-01) -
Thiopurine-S-Methyltransferase Gene Polymorphism and Drug-related Toxicity in Children Treated for Acute Leukemia and Non-Hodgkin’s Lymphoma
by: Eda Ataseven, et al.
Published: (2022-03-01) -
Exclusive enteral nutrition with concomitant early thiopurine use was effective in maintaining steroid-free remission in a Southeast Asian cohort of children with Crohn’s disease
by: Christina Ong, et al.
Published: (2018-12-01) -
Severe Complication of Thiopurine Treatment in a Young Woman with Crohn’s Disease
by: Michiel PJ Voet, et al.
Published: (2021-03-01)